logo-loader

VentriPoint Diagnostics recent grants gives company runway to execute on sales plans in 2021

Published: 16:42 14 Dec 2020 EST

Ventripoint Diagnostics (CVE: VPT- OTC: VPTDF) CEO George Adams joined Steve Darling from Proactive to provide a corporate update as the company has been given some grants to provide runway for most of next year as the world continues to deal with the global pandemic.

Adams telling Proactive, the company has been able to install its proprietary VMS +3 machines in hospitals in North America and Europe.

Ventripoint Diagnostics new Director sees strong path forward updated VMS system

Ventripoint Diagnostics (CVE: VPT-OTC: VPTDF) New Director Hugh MacNaught joined Steve Darling from Proactive to discuss his new role on the board of the company. He also shares his background and what he brings to the company. MacNaught also shared details about the news VMS technology and...

on 10/15/2020